65 related articles for article (PubMed ID: 9267073)
41. Increased soluble IL-2 receptor levels in HCV-infected haemophiliacs: a possible indicator of liver disease severity.
Makris M; Preston FE; Ralph S
Br J Haematol; 1994 Jun; 87(2):419-21. PubMed ID: 7947292
[TBL] [Abstract][Full Text] [Related]
42. Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4.
Zekri AR; Alam El-Din HM; Bahnassy AA; Zayed NA; Mohamed WS; El-Masry SH; Gouda SK; Esmat G
Comp Hepatol; 2010 Jan; 9(1):1. PubMed ID: 20051112
[TBL] [Abstract][Full Text] [Related]
43. Serum Levels of Soluble IL-2R, CD4 and CD8 in Chronic Active HCV Positive Hepatitis.
Caruso C; Candore G; Cigna D; Tripi S; Di Gaetano G; Migneco G; Montalto G; Ruggieri I; Notarbartolo A
Mediators Inflamm; 1994; 3(3):185-7. PubMed ID: 18472940
[TBL] [Abstract][Full Text] [Related]
44. An association between increased serum-soluble interleukin-2 receptors and a disturbance in muscle force in schizophrenic patients.
Rapaport MH; Caligiuri MP; Lohr JB
Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jul; 21(5):817-27. PubMed ID: 9278953
[TBL] [Abstract][Full Text] [Related]
45. Hepatocellular Carcinoma 11 and a Half Years after the Resolution of Chronic Hepatitis C Virus Infection Successfully Treated with Interferon.
Hotta N; Ayada M; Okumura A; Ishikawa T; Sato K; Oohashi T; Hijikata Y; Kakumu S
Case Rep Gastroenterol; 2009 Jul; 3(2):175-181. PubMed ID: 21103271
[TBL] [Abstract][Full Text] [Related]
46. Hepatitis C virus-related lymphomagenesis in a mouse model.
Tsukiyama-Kohara K; Sekiguchi S; Kasama Y; Salem NE; Machida K; Kohara M
ISRN Hematol; 2011; 2011():167501. PubMed ID: 22084693
[TBL] [Abstract][Full Text] [Related]
47. Interferon-alpha/beta upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocellular carcinoma cell lines and in chronic hepatitis C patients during interferon-alpha/beta treatment.
Yamaji K; Nabeshima S; Murata M; Chong Y; Furusyo N; Ikematsu H; Hayashi J
Cancer Immunol Immunother; 2006 Apr; 55(4):394-403. PubMed ID: 16041541
[TBL] [Abstract][Full Text] [Related]
48. Serum soluble interleukin-2 receptor levels before and during interferon treatment in patients with chronic hepatitis B virus infection.
Sawayama Y; Hayashi J; Kawakami Y; Furusyo N; Ariyama I; Kishihara Y; Ueno K; Kashiwagi S
Dig Dis Sci; 1999 Jan; 44(1):163-9. PubMed ID: 9952238
[TBL] [Abstract][Full Text] [Related]
49. Therapy of hepatitis C: patients with normal aminotransferase levels.
Marcellin P; Lévy S; Erlinger S
Hepatology; 1997 Sep; 26(3 Suppl 1):133S-136S. PubMed ID: 9305678
[TBL] [Abstract][Full Text] [Related]
50. Natural history of hepatitis C and the impact of anti-viral therapy.
Boyer N; Marcellin P
Forum (Genova); 2000; 10(1):4-18. PubMed ID: 10717254
[TBL] [Abstract][Full Text] [Related]
51. Elevation of serum soluble interleukin-2 receptor levels in patients with hepatitis C virus infection.
Kawakami Y; Hayashi J; Ueno K; Ohmiya M; Kishihara Y; Yamaji K; Kashiwagi S
Fukuoka Igaku Zasshi; 1997 Jul; 88(7):274-82. PubMed ID: 9267073
[TBL] [Abstract][Full Text] [Related]
52. Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection.
Kawakami Y; Nabeshima S; Furusyo N; Sawayama Y; Hayashi J; Kashiwagi S
Am J Gastroenterol; 2000 Jan; 95(1):227-32. PubMed ID: 10638589
[TBL] [Abstract][Full Text] [Related]
53. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha.
Grüngreiff K; Reinhold D; Ansorge S
Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433
[TBL] [Abstract][Full Text] [Related]
54. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
Jia HY; Du J; Zhu SH; Ma YJ; Chen HY; Yang BS; Cai HF
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
[TBL] [Abstract][Full Text] [Related]
55. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
[TBL] [Abstract][Full Text] [Related]
56. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
Kitaoka S; Shiota G; Kawasaki H
Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
